Abstract Artificial proteins can be engineered to exhibit interesting solid state, liquid crystal or interfacial properties and may ultimately serve as important alternatives to conventional polymeric materials. The utility of protein-based materials is limited, however, by the availability of just the 20 amino acids that are normally recognized and utilized by biological systems; many desirable functional groups cannot be incorporated directly into proteins by biosynthetic means. In this study, we incorporate para-bromophenylalanine (p-Br-phe) into a model target protein, mouse dihydrofolate reductase (DHFR), by using a bacterial phenylalanyl-tRNA synthetase (PheRS) variant with relaxed substrate specificity. Coexpression of the mutant PheRS and DHFR in a phenylalanine auxotrophic Escherichia coli host strain grown in p-Br-phe-supplemented minimal medium resulted in 88% replacement of phenylalanine residues by p-Br-phe; variation in the relative amounts of phe and p-Br-phe in the medium allows control of the degree of substitution by the analog. Protein expression yields of 20^25 mg/l were obtained from cultures supplemented with p-Br-phe; this corresponds to about two-thirds of the expression levels characteristic of cultures supplemented with phe. The aryl bromide function is stable under the conditions used to purify DHFR and creates new opportunities for post-translational derivatization of brominated proteins via metal-catalyzed coupling reactions. In addition, bromination may be useful in X-ray studies of proteins via the multiwavelength anomalous diffraction (MAD) technique.
Introduction
Protein engineering provides a powerful tool for modi¢ca-tion of the structural and functional properties of proteins as well as for designing new macromolecular substances with precise control of composition and architecture. Several polymeric materials with interesting properties have been synthesized by protein engineering methods [1^4] . For many applications of these macromolecules, it will be desirable to develop methods for incorporation of amino acids containing novel chemical functionality not possessed by the 20 proteinogenic amino acids. New functionality can be exploited to probe protein structure and function, to alter stability and folding behavior, and to open new avenues for post-translational modi¢cation.
Biosynthetic incorporation of non-canonical amino acids into proteins has been achieved in Escherichia coli largely by exploiting the capacity of the wild-type protein synthesis apparatus to utilize analogs of the natural amino acids [5^11] . However, use of a wider range of analogs will require that the substrate speci¢city of the aminoacyl-tRNA synthetases (aaRS) is relaxed or changed altogether. The in vitro method of unnatural amino acid incorporation, introduced by Hecht and coworkers [12] , uses chemically acylated tRNAs and thereby circumvents the checkpoint of the aaRS; this method has found extensive application in amino acid replacement in a site-speci¢c manner [13^15] . A further advance in site-speci¢c replacement was the demonstration of in vivo incorporation of an amino acid analog by using a yeast suppressor tRNA amber /aaRS pair in an analog-resistant E. coli strain [16] .
We have previously exploited the ability of E. coli to incorporate para-£uorophenylalanine (p-F-phe) into repetitive polypeptides with high e¤ciency [10] . While £uorinated polypeptide materials are likely to exhibit novel surface properties, they are inert to chemical modi¢cation under mild conditions. We therefore turned our attention to para-bromophenylalanine (p-Br-phe), which we anticipate will be readily modi¢ed owing to the higher reactivity of the aryl bromide functional group [17^22]. Moreover, bromination may be useful in X-ray structure determination of proteins by multiwavelength anomalous di¡raction (MAD). Brominated nucleic acids have been used successfully for determination of the structures of DNAd rug complexes, DNA^protein complexes, DNAs and RNAs [23^27]. We suggest that p-Br-phe may eventually complement selenomethionine [28, 29] in structure determination of proteins by the MAD technique.
While the wild-type E. coli protein synthesis machinery can utilize phenylalanine (phe) and p-F-phe, the analog p-Br-phe is not recognized by the wild-type phenylalanyl-tRNA synthetase (PheRS). In 1991, however, Kast and Hennecke reported an engineered mutant form of this enzyme (Gly294PheRS) which charges tRNA Phe with p-Cl-Phe in vivo and appears to enable incorporation of even p-Br-phe into cellular protein [30^32] . In the present work, we employed this mutant to e¡ect e¤cient in vivo incorporation of p-Br-phe into mouse dihydrofolate reductase (DHFR) in bacterial cells.
Materials and methods

Plasmids and E. coli strains
The plasmid pKSS bears the gene for the Gly-294 variant K-subunit of the PheRS (termed pheS*) [33] . pheS* was subcloned from pKSS by PCR mutagenesis such that two SphI restriction sites, one at either end outside of the pheS* gene, were generated by single-base insertions (SphI sites were designed for another purpose). The 1722 bp PCR-ampli¢ed fragment was cloned into a pUC19 cloning vector at the SmaI site. The pheS* gene was cut out as an SphI fragment, bluntended, and inserted into the PvuII site of the expression plasmid pQE15 (Qiagen). The resulting plasmid, designated pQE-FS, carries the gene for the target protein DHFR under bacteriophage T5 promoter control and that for pheS* under lac promoter control. The repressor plasmid pLysS (Novagen) was modi¢ed so that it contained the lacI q gene for lac repressor as a SalI fragment from the plasmid pREP4 (Qiagen); the resulting plasmid was designated pLysS-IQ.
A phenylalanine auxotrophic derivative of E. coli strain BL21(DE3), called AF, previously constructed in our laboratory, was used as host [10] . The AF strain with the repressor plasmid pLysS-IQ was designated AF-IQ. AF-IQ cells were transformed with pQE-FS or with control plasmid pQE15.
Gene expression and incorporation of p-Br-phe into DHFR
The in vivo translational activity of p-Br-phe was ¢rst investigated on a small scale. Bacterial cultures were grown in M9 minimal medium [34] Larger scale production of DHFR was carried out in 1 l cultures of AF-IQ[pQE-FS] grown in the medium described above. Cells were sedimented and the cell pellet was resuspended in supplemented M9 medium containing p-Br-phe at 500 mg/l; expression of DHFR was induced 10 min after the medium shift with 1 mM IPTG. In experiments to control the degree of bromination of DHFR, the induction medium was supplemented with varying amounts of phe and p-Br-phe (see Table 1 ).
Isolation and analysis of brominated target protein
DHFR as expressed from pQE15-derived plasmids contains an Nterminal hexahistidine sequence, which was utilized for protein puri¢cation by nickel-a¤nity chromatography with step-wise pH gradient elution under denaturing conditions (Qiagen). Eluted protein was dialyzed against distilled water and lyophilized, and the puri¢ed protein was subjected to amino acid compositional analysis.
Extraction of cellular free amino acids
In order to determine the cellular concentrations of free phe and pBr-phe, 250 ml cell cultures were grown in M9 medium supplemented with all 20 amino acids at 20 mg/l. The cells were harvested at OD 600 = 1, washed twice with 0.9% NaCl and treated as follows: (i) subjected to analysis as such, or (ii) incubated for 2 h in M9 medium lacking phe and containing IPTG, p-Br-phe, both or neither as described in Fig. 2 . Free amino acids were extracted by a modi¢ed version of the protocol of Raunio and Rosenqvist [35] ; harvested cells were resuspended in 5 ml distilled water, and the suspension adjusted to pH 10 with a few drops of 5 N NH 4 OH. The suspension was incubated without shaking for 10 min at 100³C in a water bath. After cooling, the pH was adjusted to about 2 by addition of HCl. The precipitate thus obtained was removed by centrifugation at 4000Ug for 10 min at 4³C. The supernatant was frozen and a 100 Wl aliquot was lyophilized and subjected to amino acid compositional analysis. Similar experiments were conducted using M9 medium supplemented (at 20 mg/l) with just the three amino acids that are essential for growth of the AF strain viz. proline, arginine and phenylalanine.
Results
Gly294PheRS allows p-Br-phe incorporation into proteins
An AF-IQ[pQE-FS] culture was grown in supplemented M9 minimal medium to an OD 600 of 0.8^1.0, and then shifted to a medium containing either (i) p-Br-phe, (ii) phe (positive control) or (iii) no phe or p-Br-phe (negative control). Expression of DHFR was induced for 4 h with 1 mM IPTG. A control expression experiment was done with AF-IQ[pQE15], which contains only the wild-type PheRS. No expression of DHFR was observed in the negative control cultures or in the AF-IQ[pQE15] culture containing p-Br-phe. On the other hand, AF-IQ[pQE-FS] cultures supplemented with p-Br-phe expressed DHFR (albeit at lower levels than the positive controls), as noted from SDS^PAGE analysis of the respective whole cell lysates (Fig. 1) . The target proteins were puri¢ed by nickel-a¤nity chromatography. The yield of puri¢ed target protein isolated from AF-IQ[pQE-FS] cells grown in p-Brphe-supplemented medium (DHFR-Br) was 20^25 mg/l, which is approximately 70% of the yield of DHFR obtained from the same cells grown in medium supplemented with phe. Amino acid analysis of puri¢ed DHFR-Br indicated up to 88% substitution of phe residues (there are nine phe residues in DHFR) by p-Br-phe. The decrease in phe content was compensated by an increase in p-Br-phe content, indicating that p-Br-phe is stable under the conditions of protein puri¢-cation and amino acid analysis.
Control of degree of substitution
For many purposes of post-translational chemical modi¢-cation of proteins, complete substitution by the analog may not be necessary (or may even be detrimental). We explored the possibility of gaining control over p-Br-phe incorporation 28  60  5  250  0  20  46  6  500  0  24  88  7  750  0  24  87  8  1000  0  22  78  9  500  1  28  70  10  500  2  30  65  11  250  2  30  20 Cells were grown to an OD 600 of 1, harvested, washed twice and then shifted to medium containing the indicated amounts of phe and p-Brphe. No media shift indicates that the cells were not washed and in that case, phe indicates the initial concentration supplied at the start of the culture.
by supplementing the medium with varying amounts of phe and p-Br-phe during target protein expression. AF-IQ[pQE-FS] cells were grown in M9 medium as before and shifted to media containing the amounts of phe and p-Br-phe indicated in Table 1 . The results shown in Table 1 compare the levels of p-Br-phe incorporation and the yields of protein obtained for di¡erent concentrations of phe and p-Br-phe. The bromination level increases with increasing concentrations of p-Br-phe up to 500 mg/l ; higher concentrations of p-Br-phe do not change the degree of incorporation further under our conditions (experiments 5^8). Addition of phe along with p-Br-phe improves the yield of protein modestly while reducing the degree of bromination as expected (experiments 9^11). Addition of p-Br-phe to growing cultures at the time of induction without the removal of phe resulted in very low levels of incorporation of the analog when the initial phe concentration was high (i.e. 20 mg/l). When the culture medium initially contained only 8 mg/l of phe, the level of substitution increased to about 60% (experiments 2^4).
Determination of free amino acids in the cell
In an attempt to understand why we did not observe complete replacement of phe by p-Br-phe, we determined the intracellular concentrations of free phe and p-Br-phe in AF-IQ[pQE-FS] cells under di¡erent growth conditions. We were particularly interested in the possibility that starvation for phe, induction of the T5 promoter and subsequent overexpression of DHFR, addition of p-Br-phe or a combination of these events might lead to a stress response and enhance cellular protein turnover, thereby increasing the cellular pool of phe. Cells were grown in the presence of phe, washed twice with saline and then grown in the presence of IPTG, p-Br-phe, or both, as described in Section 2. After 2 h of incubation, the amounts of free cellular phe and p-Br-phe were determined. The results in Fig. 2 indicate that the phe concentration does not vary signi¢cantly under the conditions examined and remains at 0.65 þ 0.15 WM, signi¢cantly lower than that supplied to the medium (120 WM). The concentration of cellular p-Brphe was found to be 14^17 times higher than that of phe, but remained in the micromolar range even when the amount supplied to the culture medium was in the millimolar range. Similar results were obtained when cells were grown in the presence of just the three amino acids essential for growth of the AF strain. Incomplete replacement of phe thus appears to be a simple consequence of the fact that the medium shift does not remove the last traces of the natural amino acid from the culture.
Discussion
Incorporation of p-Br-phe into short peptides by solid state peptide synthesis has been reported previously [36^38] . The results reported here constitute the ¢rst demonstration of an e¤cient strategy for incorporation of p-Br-phe into protein in vivo. This was achieved by coexpression of the gene for a PheRS variant with relaxed substrate speci¢city, along with the gene encoding the protein of interest, in an E. coli host strain auxotrophic for phenylalanine. The E. coli strain we use still expresses its wild-type PheRS K-subunit; however, since the mutant PheRS K-subunit is produced from several plasmid-borne gene copies, most functional PheRS molecules (which have the oligomeric structure [KL] 2 [39, 40] ) are likely to contain the mutant subunit and thus possess the ability to utilize p-Br-phe. High levels of replacement (88%) of phenylalanine by its brominated analog have been achieved. The brominated analog is stable once incorporated into protein, and the yield of brominated protein is high enough for sample-intensive methods such as post-translational modi¢cation, nuclear magnetic resonance or crystallographic structure determination.
Controlling the amount of p-Br-phe substitution may be advantageous for many applications, e.g. post-translational modi¢cation, as it may not be necessary to replace all of the phenylalanine residues by the brominated analog. The level of analog incorporation can be controlled by varying the relative amounts of phe and p-Br-phe in the culture medium at the time of induction of target gene expression. The success shown here with the model protein (DHFR) is likely to be applicable to other proteins as well.
The in vivo method for unnatural amino acid incorporation described here is complementary to the in vitro approach, which can accommodate a wider range of analogs at a single programmed site using chemically misacylated tRNAs [121 4] . The in vivo approach, on the other hand, is best suited for substitution by an analog at multiple sites and for obtaining higher protein yields. The method described here allows routine isolation of tens to hundreds of mg of labeled protein within days at reasonable cost. Cells were grown to an OD 600 = 1, centrifuged, washed twice with NaCl and subjected to treatment as indicated above. Concentration of IPTG = 1 mM; p-Br-phe = 2 mM. Fig. 1 . pheS* allows utilization of p-Br-phe as a substrate for PheRS. Production of DHFR in the p-Br-phe-supplemented medium is observed only from plasmid pQE-FS wherein the gene for the mutant enzyme with relaxed substrate speci¢city, pheS*, is present. Cells transformed with pQE15 lack the mutant enzyme and cannot utilize p-Br-phe to make DHFR. In the negative control, which contains neither phe nor p-Br-phe (lanes marked 3), there is no DHFR, con¢rming auxotrophy for phenylalanine. Concentration of phe = 20 mg/l; p-Br-phe = 500 mg/l.
Introduction of aryl bromide functionality opens possibilities for a variety of controlled chemical modi¢cations of engineered proteins, many of which are not possible with the 20 natural amino acids. Aromatic halides are known to undergo metal-catalyzed coupling, amidation, cyanation and related reactions, under mild conditions [17^22] . Application of these chemistries to genetically engineered proteins would allow for new approaches to side-chain modi¢cation, coupling with various ligands, immobilization on surfaces, and synthesis of graft copolymers and cross-linked gels. Bromination may also provide a new tool for use in X-ray di¡raction studies of protein structure, though we do not yet know the extent to which p-Br-phe residues may perturb protein folding. Brominated pyrimidine bases have been successfully used as anomalous scatterers for structure determination of DNA^drug complexes, DNA^protein complexes and other nucleic acids [23^27] . We suggest that p-Br-phe is likely to ¢nd similar uses in crystallographic studies of protein structure.
